The BIO/Thomson Reuters Investor Perception Study
This study is an in-depth assessment of Wall Street’s views of the biotech industry, its current challenges, its relative valuation, and the outlook for 2009. The analysis aims to provide BIO members with an insider’s perspective on what the investment community values in the current economic climate and help foster more effective communication between company management, shareholders, and potential investors.
Read the study

Some Facts About Biotechnology / Industry Statistics
From BIO's Guide to Biotechnology (updated early 2007)
Read the report

Global biotech crop acreage increases in 2007 (Jan. 2007)
Read the summaries and press releases

Time Line of Biotechnology
Read the time line